VibekeStrandMD

PubMed

• Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial.
  Laure Gossec, Laura C Coates, Alexis Ogdie, Jiyoon Choi, Brandon Becker, Joe Zhuo, Thomas Lehman, Ayanbola Elegbe, Philip J Mease, Atul Deodhar, Vibeke Strand, Mirosla...> ;Arthritis Care & Research. 2024 Mar 26
• Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023.
  Beverley Shea, Jordi Pardo Pardo, Shawna Grosskleg, Dorcas E Beaton, Philip Conaghan, Wim Goettsch, Catherine Hofstetter, Lara Maxwell, Joachim Musaus, Daniel Ollendor...> ;Seminars in Arthritis and Rheumatism. 2024 Mar 16
• Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review.
  Lourdes M Pérez-Chada, Zachary H Hopkins, Deepak M W Balak, Sarem Rashid, Andrew Creadore, Brian Chu, Camila Villa, Michael J Woodbury, April W Armstrong, Vibeke Stran...> ;JAMA Dermatology. 2024 Jan 24
• The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.
  Rachael A Gordon, Yann Nguyen, Nathan Foulquier, Maxime Beydon, Tamer A Gheita, Raouf Hajji, Ilfita Sahbudin, Alberta Hoi, Wan-Fai Ng, Jose Alexandre Mendonça, Daniel ...> ;Seminars in Arthritis and Rheumatism. 2024 Apr 1
• Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
  Simon Décary, Maarten de Wit, Florian Naye, Jennifer L Barton, Liana Fraenkel, Linda C Li, Peter Brooks, Dawn Stacey, Lara J Maxwell, Willemina Campbell, Cathie Hofste...> ;Seminars in Arthritis and Rheumatism. 2024 Apr 1
• OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
  Wils Nielsen, Vibeke Strand, Lee S Simon, Ioannis Parodis, Alfred H J Kim, Maya Desai, Yvonne Enman, Daniel Wallace, Yashaar Chaichian, Sandra Navarra, Cynthia Aranow,...> ;Seminars in Arthritis and Rheumatism. 2024 Apr 1
• OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments.
  Florian Naye, Karine Toupin-April, Maarten de Wit, Annie LeBlanc, Olivia Dubois, Annelies Boonen, Jennifer L Barton, Liana Fraenkel, Linda C Li, Dawn Stacey, Lyn March...> ;Seminars in Arthritis and Rheumatism. 2024 Apr 1
• Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop.
  Pickles, T., Cowern, M., Christensen, R., Nielsen, S., Jones, C., Maxwell, L., Shea, B., Touma, Z., Toupin-April, K., Choy, E., Simon, L., Strand, V., Mease, P.> ;Seminars in Arthritis and Rheumatism. 2024 Feb 1
• Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
  Benavent, D., Carmona, L., Lopez-Olivo, M., Hill, C., Westrich-Robertson, T., Goel, N., Strand, V., Shea, B., Grosskleg, S., Leong, A., Hofstetter, C., Bingham, C., Me...> ;Seminars in Arthritis and Rheumatism. 2024 Feb 1
• 1 citations
  Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic li...
  Lihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, Jennifer Petkovic, Vibeke Strand, Philip Mease, Keith Colaco> ;The Lancet. Rheumatology. 2023 Dec 1
• More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
  Zahi Touma, Ioannis Parodis, Vibeke Strand> ;The Journal of Rheumatology. 2023 Nov 15
• Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis.
  Jeffrey R Curtis, Vibeke Strand, Steven J Golombek, George A Karpouzas, Lixia Zhang, Angus Wong, Krishna Patel, Jennifer Dines, Viatcheslav R Akmaev> ;Rheumatology and Therapy. 2024 Feb 1
• 1 citations
  25 years of biologic DMARDs in rheumatology.
  Marc Feldmann, Ravinder N Maini, Enrique R Soriano, Vibeke Strand, Tsutomu Takeuchi> ;Nature Reviews. Rheumatology. 2023 Dec 1
• Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
  Dorthe B Berthelsen, Lee S Simon, John P A Ioannidis, Marieke Voshaar, Pam Richards, Niti Goel, Vibeke Strand, Sabrina M Nielsen, Beverly J Shea, Peter Tugwell, Susan ...> ;Seminars in Arthritis and Rheumatism. 2023 Dec 1
• 4 citations
  Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phas...
  Roy M Fleischmann, Désirée van der Heijde, Vibeke Strand, Tatsuya Atsumi, Iain B McInnes, Tsutomu Takeuchi, Peter C Taylor, Marguerite Bracher, David Brooks, John Davi...> ;Annals of the Rheumatic Diseases. 2023 Dec 1
• 3 citations
  Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (con...
  Peter C Taylor, Michael E Weinblatt, Iain B McInnes, Tatsuya Atsumi, Vibeke Strand, Tsutomu Takeuchi, Marguerite Bracher, David Brooks, John Davies, Christopher Goode,...> ;Annals of the Rheumatic Diseases. 2023 Dec 1
• 3 citations
  The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from ...
  Jayne, D., Yue, H., Bekker, P., , Strand, V., Horomanski, A., Merkel, P.> ;The Lancet. Rheumatology. 2023 Aug 1
• Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting.
  Melissa P Zundell, Michael J Woodbury, Kathryn Lee, Lourdes M Perez-Chada, April W Armstrong, Vibeke Strand, Joseph F Merola, Alice B Gottlieb> ;The Journal of Rheumatology. 2023 Nov 1
• 3 citations
  The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
  Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi, Robert Terkeltaub, Nicola Dalbeth, Wesley DeHaan, Rehan Azeem, Peter G Traber, Robert T Ke...> ;Rheumatology. 2024 Apr 2
• 1 citations
  Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
  Ying-Ying Leung, William Tillett, Maarten de Wit, Ana-Maria Orbai, Laura C Coates, Oliver FitzGerald, Philip S Helliwell, Vibeke Strand, Philip J Mease, Niti Goel, Rob...> ;The Journal of Rheumatology. 2023 Nov 1
• 2 citations
  Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group.
  Wils Nielsen, Vibeke Strand, Lee S Simon, Julian Thumboo, Marta Mosca, Martin Aringer, Eric F Morand, Ian Bruce, Zahi Touma> ;Lupus. 2023 Apr 1
• 6 citations
  Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-t...
  Lihi Eder, Dafna D Gladman, Philip Mease, Remy A Pollock, Rayana Luna, Sibel Z Aydin, Alexis Ogdie, Ari Polachek, David Gruben, Mary Jane Cadatal, Cassandra Kinch, Vib...> ;RMD Open. 2023 Mar 1
• Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
  Gerd R Burmester, Vibeke Strand, Alan J Kivitz, Chih-Chi Hu, Sheldon Wang, Hubert van Hoogstraten, Gabriella L Klier, Roy Fleischmann> ;Rheumatology. 2023 Oct 3
• 3 citations
  Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis.
  Jeffrey R Curtis, Vibeke Strand, Steven Golombek, Lixia Zhang, Angus Wong, Mark C Zielinski, Viatcheslav R Akmaev, Alif Saleh, Sam Asgarian, Johanna B Withers> ;Expert Review of Molecular Diagnostics. 2022 Nov 3
• 1 citations
  Overview of biosimilars for immune-mediated inflammatory diseases: summary of current evidence.
  Vibeke Strand, Colby Evans, Allan Gibofsky> ;The American Journal of Managed Care. 2022 Nov 1
• Join now to see all

Journal Articles

• Health-Related Quality of Life in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomised Controlled Trial  
  Micki Klearman, Vibeke Strand, John H Stone, BioMed Central
• Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus: 6 Years of Treatment  
  Vibeke Strand, MD, Arthritis Care & Research
• Blood Concentrations of Complement Split Product iC3b and Serum C3 Associate with SLE Disease Activity  
  Deepali P Sen, John P Atkinson, Vibeke Strand, Arthritis & Rheumatology
• Ixekizumab Improves Patient-Reported Outcomes up to 52 Weeks in bDMARD-Naïve Patients with Active Psoriatic Arthritis (SPIRIT-P1)  
  Alice B Gottlieb, Vibeke Strand, Rheumatology
• Patient-Reported Outcomes from a Randomized Phase III Trial of Sarilumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis  
  Vibeke Strand, MD, BioMed Central
• Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis over 2 Years: Results from the FUTURE 2 Study  
  Philip J Mease, Vibeke Strand, BioMed Central
• Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016  
  Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
• Response to M Boers concerns about Spydergrams  
  Strand V, Loftis J, Journal of Clinical Epidemiology, 1/1/2013
• Prevalence of Axial SpA in US Rheumatology Practices: Assessment of ASAS Criteria vs Rheumatology Expert Clinical Diagnosis  
  Strand V, Rao S, Shillington A, Cifaldi MA, McGuire M, Ruderman E, Arth Care & Research, 1/1/2013
• Improvements in Health Related Quality of Life with Belimumab, A B-lymphocyte Stimulator-specific Inhibitor, in Patients with Autoantibody-positive Systemic Lupus Eryt...  
  Strand V, Levy R, Cervera R, Petri MA, Birch H, Freimuth WW, Zhong J, Clarke AE for the BLISS-52 and -76 Study Groups, Annals Rheum Ds, 1/1/2013
• Efficacy and Safety of Epratuzumab in Patients with Moderate/Severe Active Systemic Lupus Erythematosus: Results from Emblem, A Phase Iib Randomized, Double Blind, Pla...  
  Wallace DJ, Kalunian K, Petri M, Strand V, Houssiau F, Pike M, Kilgallen B, Bongardt S, Barry A, Kelley L, Gordon C, Ann Rheum Ds, 1/1/2013
• Efficacy and Safety of Epratuzumab in Patients with Moderate/Severe Flaring Systemic Lupus Erythematosus: Results from Two Randomized, Double-blind, Placebo-controlled...  
  Wallace D, Gordon C, Strand V, Hobbs K, Petri M, Kalunian K, Houssiau F, Tak PP, Isenberg D, Kelley L, Kilgallen B, Barry AN, Wegener W, Goldenberg DM, Rheumatol, 1/1/2013
• From "inhibition of Radiographic Progression" to "maintaining Structural Integrity"  
  Landewe R, Strand V, van der Heijde D, Ann Rheum Ds, 1/1/2013
• Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study  
  Strand V, Schett G, Hu CC, Stevens R, J Rheumatol, 1/1/2013
• Predictors of Self Reported Health Related Quality of Life in Systemic Lupus Erythematosus (SLE)  
  Kiani AK, Strand V, Fang H, Jaranilla J, Petri M, Rheumatology, 1/1/2013
• Improvements in Patient-reported Outcomes with Apremilast, A Novel, Oral, Small Molecule, in the Treatment of Moderate to Severe Psoriasis: Results from a Phase IIb Ra...  
  Strand V, Fiorentino D, Hu C, Stevens R, Papp K, Health and QOL Review, 1/1/2013
• Reduced Joint Counts Misclassify Patients with Oligoarticular Psoriatic Arthritis and Miss Significant Numbers of Patients with Active Disease  
  Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, Helliwell PS on behalf of the GRACE Collaboration, Arth Rheum, 1/1/2013
• The Utility of Magnetic Resonance Imaging for Assessing Structural Damage in Randomized Controlled Trials in Rheumatoid Arthritis  
  Raganeth V, Strand V, Peterfy C, Ostergaard M, Deodhar A, Landewe R, Troum O, Conaghan P, Arth Rheum, 1/1/2013
• Long-term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-year Results from the RAPID 1 Trial an...  
  Keystone E, Landewe R, van Vollenhoven R, Combe B, Strand V et al, Ann Rheum Ds, 1/1/2013
• Epratuzumab for Patients with Moderate to Severe Flaring SLE: Health-related Quality of Life Benefits and Corticosteroid Use in the Randomized Controlled ALLEVIATE Tri...  
  Strand V, Petri M, Kalunian K, Gordon C, Wallace DJ, Hobbs K, Kelley L, Kilgallen B, Wegener WA, Goldenberg DM, Rheumatology, 1/1/2013
• Biosimilars: How similar?  
  Strand V, Cronstein B, Internal Medicine Journal, 1/1/2013
• Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core-Sets of Domains and Instruments for Use in Clinical Tr...  
  Sakatoo LA, Huscher D, Khanna D, Dellaripa PF, Distler O, Flarherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, ..., Thorax, 1/1/2013
• Comparison of Health-related Quality of Life in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis and Effects of Etanercept Treatment  
  Strand V, Sharp V, Koenig A, Park G, Shi Y, Wang B, Zack DJ, Fiorentino D, Ann Rheum Ds, 1/1/2012
• A Multicenter, Randomized Controlled Trial Comparing A Single Intra-articular Injection of Gel-200, A New Cross-linked Formulation of Hyaluronic Acid to Phosphate Buff...  
  Strand V, Baraf H, Lavin PT, Lim S, Hosokawa H, Osteoarth Cart, 1/1/2012
• A Phase II, Double-blind, Randomized, Placebo-controlled Study of BMS945429 (ALD518) in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate  
  Mease P, Strand V, Shalamberidze L, Dimic A, Raskina T, Xu L-A, Liu Y, Smith J and BMS945429 Study Group, Ann Rheum Ds, 1/1/2012
• Join now to see all

Other

• Functional Impairment Measurement in Psoriatic Arthritis: Importance and Challenges 
  Vibeke Strand, MD, Seminars in Arthritis & Rheumatism
  https://www.doximity.com/articles/09f8e5df-563f-4b90-b4e7-20086edbdd5c
  UpToDate, Wolters Kluwer Health - 2012-04-18